Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
Background & Aims: Two European randomized trials (N = 30,000) compared guaiac fecal occult blood testing with quantitative fecal immunochemical testing (FIT) and showed better attendance rates and test characteristics for FIT. We aimed to identify the most cost-effective FIT cutoff level for referral to colonoscopy based on data from these trials and allowing for differences in screening ages. Methods: We used the validated MIcrosimulation SCreening ANalysis (MISCAN)-Colon microsimulation model to estimate costs and effects of different screening strategies for FIT cutoff levels of 50, 75, 100, 150, and 200 ng/mL hemoglobin. For each cutoff level, screening strategies were assessed with various age ranges and screening intervals. We assumed sufficient colonoscopy capacity for all strategies. Results: At all cost levels, FIT screening was most effective with the 50 ng/mL cutoff level. The incremental cost-effectiveness ratio of biennial screening between ages 55 and 75 years using FIT at 50 ng/mL, for example, was 3900 euro per life year gained. Annual screening had an incremental cost-effectiveness ratio of 14,900 euro per life year gained, in combination with a wider age range (between ages 45 and 80 years). In the sensitivity analysis, 50 ng/mL remained the preferred cutoff level. Conclusions: FIT screening is more cost-effective at a cutoff level of 50 ng/mL than at higher cutoff levels. This supports the recommendation to use FIT at a cutoff level of 50 ng/mL, which is considerably lower than the values used in current practice.
|Keywords||Colon Cancer, Colorectal Neoplasia, Cost Analysis, Decision Support Analysis|
|Persistent URL||dx.doi.org/10.1053/j.gastro.2011.07.020, hdl.handle.net/1765/33245|
Wilschut, J.A., Hol, L., Dekker, E., Jansen, J.B., van Leerdam, M.E., Lansdorp-Vogelaar, I., … van Ballegooijen, M.. (2011). Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology, 141(5), 1648–1655. doi:10.1053/j.gastro.2011.07.020